EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants

Jenny Wegert iD, Anne Kristin Fischer, Balazs Palhazi, Taryn D Treger, Cäcilia Hilgers, Barbara Ziegler, Hyunchul Jung, Eva Jüttner, Andreas Waha, Jörg Fuchs, Steven W Warmann, Michael C Frühwald and 7 more

The Journal of Pathology · 2024

DOI: 10.1002/path.6206 ↗

At a glance

Journal article in The Journal of Pathology, 2024. Written by Jenny Wegert and 18 co-authors. Institution: Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry, University of Wuerzburg, Wuerzburg, Germany. Major MEDLINE topics: Kidney Neoplasms, Wilms Tumor. Cited 17 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Cancer Research UK, Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Wilms tumors (WTs) are histologically diverse childhood cancers with variable contributions of blastema, stroma, and epithelia. A variety of cancer genes operate in WTs, including the tripartite‐motif‐containing‐28 gene ( TRIM28 ). Case reports and small case series suggest that TRIM28 mutations are associated with epithelial morphology and WT predisposition. Here, we systematically investigated the prevalence of TRIM28 inactivation and predisposing mutations in a cohort of 126 WTs with >2/3 epithelial cells, spanning 20 years of biobanking in the German SIOP93‐01/GPOH and SIOP2001/GPOH studies. Overall, 44.4% (56/126) cases exhibited loss of TRIM28 by immunohistochemical staining. Of these, 48 could be further analyzed molecularly, revealing TRIM28 sequence variants in each case – either homozygous (~2/3) or heterozygous with epigenetic silencing of the second allele (~1/3). The majority (80%) of the mutations resulted in premature stops and frameshifts. In addition, we detected missense mutations and small deletions predicted to destabilize the protein through interference with folding of key structural elements such as the zinc‐binding clusters of the RING, B‐box‐2, and PHD domains or the central coiled‐coil region. TRIM28‐ mutant tumors otherwise lacked WT‐typical IGF2 alterations or driver events, except for rare TP53 progression events that occurred with expected frequency. Expression profiling identified TRIM28‐ mutant tumors as a homogeneous subset of epithelial WTs that mostly present with stage I disease. There was a high prevalence of perilobar nephrogenic rests, putative precursor lesions, that carried the same biallelic TRIM28 alterations in 7/7 cases tested. Importantly, 46% of the TRIM28 mutations were present in blood cells or normal kidney tissue, suggesting germline events or somatic mosaicism, partly supported by family history. Given the high prevalence of predisposing variants in TRIM28‐ driven WT, we suggest that immunohistochemical testing of TRIM28 be integrated into diagnostic practice as the management of WT in predisposed children differs from that with sporadic tumors. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Kidney NeoplasmsWilms TumorChildHumansBiological Specimen BanksKidneyGerm-Line MutationDisease SusceptibilityTripartite Motif-Containing Protein 28

Author keywords

TRIM28Wilms tumorepithelial WTgenetic tumor predispositiontransposable elements

Substances

TRIM28 protein, humanTripartite Motif-Containing Protein 28

Authors and institutions

  • Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry, University of Wuerzburg, Wuerzburg, Germany.
  • Department of Pathology, University of Cologne, Cologne, Germany.
  • Wellcome Sanger Institute, Hinxton, UK.
  • Department of Paediatrics, University of Cambridge, Cambridge, UK.
  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Department of Pathology, Section of Pediatric Pathology, University of Bonn, Bonn, Germany.

ORCID profiles: Jenny Wegert, Norbert Graf, Manfred Gessler

Funding

  • Cancer Research UK
  • Deutsche Forschungsgemeinschaft
  • Deutsche Krebshilfe
  • Little Princess Trust

Cite

APA

Wegert, J., Fischer, A. K., Palhazi, B., Treger, T. D., Hilgers, C., Ziegler, B., Jung, H., Jüttner, E., Waha, A., Fuchs, J., Warmann, S. W., Frühwald, M. C., Hubertus, J., Pritchard-Jones, K., Graf, N., Behjati, S., Furtwängler, R., Gessler, M., & Vokuhl, C. (2024). TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants. The Journal of Pathology. https://doi.org/10.1002/path.6206

Vancouver

Wegert J, Fischer AK, Palhazi B, Treger TD, Hilgers C, Ziegler B, et al. TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants. The Journal of Pathology. 2024. doi:10.1002/path.6206

BibTeX
@article{Wegert2024,
  author = {Wegert, Jenny and Fischer, Anne Kristin and Palhazi, Balazs and Treger, Taryn D and Hilgers, Cäcilia and Ziegler, Barbara and Jung, Hyunchul and Jüttner, Eva and Waha, Andreas and Fuchs, Jörg and Warmann, Steven W and Frühwald, Michael C and Hubertus, Jochen and Pritchard-Jones, Kathy and Graf, Norbert and Behjati, Sam and Furtwängler, Rhoikos and Gessler, Manfred and Vokuhl, Christian},
  title = {TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6206}
}
Start for free →